Unknown

Dataset Information

0

Consensus guidelines for management of hyperammonaemia in paediatric patients receiving continuous kidney replacement therapy.

ABSTRACT: Hyperammonaemia in children can lead to grave consequences in the form of cerebral oedema, severe neurological impairment and even death. In infants and children, common causes of hyperammonaemia include urea cycle disorders or organic acidaemias. Few studies have assessed the role of extracorporeal therapies in the management of hyperammonaemia in neonates and children. Moreover, consensus guidelines are lacking for the use of non-kidney replacement therapy (NKRT) and kidney replacement therapies (KRTs, including peritoneal dialysis, continuous KRT, haemodialysis and hybrid therapy) to manage hyperammonaemia in neonates and children. Prompt treatment with KRT and/or NKRT, the choice of which depends on the ammonia concentrations and presenting symptoms of the patient, is crucial. This expert Consensus Statement presents recommendations for the management of hyperammonaemia requiring KRT in paediatric populations. Additional studies are required to strengthen these recommendations.

SUBMITTER: Raina R 

PROVIDER: S-EPMC7366888 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Hyperammonaemia in children can lead to grave consequences in the form of cerebral oedema, severe neurological impairment and even death. In infants and children, common causes of hyperammonaemia include urea cycle disorders or organic acidaemias. Few studies have assessed the role of extracorporeal therapies in the management of hyperammonaemia in neonates and children. Moreover, consensus guidelines are lacking for the use of non-kidney replacement therapy (NKRT) and kidney replacement therapi  ...[more]

Similar Datasets

Unknown Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy.
| S-EPMC7096894 | biostudies-literature
Unknown Pharmacokinetic profile of acyclovir in a child receiving continuous kidney replacement therapy for acute liver failure.
| S-EPMC9880359 | biostudies-literature
Unknown Management of regional citrate anticoagulation for continuous renal replacement therapy: guideline recommendations from Chinese emergency medical doctor consensus.
| S-EPMC10226261 | biostudies-literature
Unknown Renal replacement therapy in acute kidney injury: controversy and consensus.
| S-EPMC4386097 | biostudies-literature
Unknown The Association of an Early Net Ultrafiltration Rate and 28-Day Mortality in Patients Receiving Continuous Kidney Replacement Therapy.
| S-EPMC8674682 | biostudies-literature
Unknown Net ultrafiltration rate and its impact on mortality in patients with acute kidney injury receiving continuous renal replacement therapy.
| S-EPMC7886538 | biostudies-literature
Unknown European Society for Paediatric Endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism.
| S-EPMC4207909 | biostudies-literature
Unknown Doripenem dosing recommendations for critically ill patients receiving continuous renal replacement therapy.
| S-EPMC3409546 | biostudies-literature
Unknown Criteria for Continuous Kidney Replacement Therapy Cessation in ICU Patients.
| S-EPMC9909622 | biostudies-literature
Unknown Elevated mean arterial pressure is associated with a lower risk of mortality in acute kidney injury patients receiving continuous renal replacement therapy.
| S-EPMC10367572 | biostudies-literature